Back to results
US 2022/0009978 A1Published application
Composition for preventing or treating autoimmune disease based on lrr domain of nlrx1 protein
AssigneeIucf-Hyu (Industry-University Cooperation Foundation Hanyang University)
InventorsJe-Min CHOI, Ja-Hyun KOO
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a fusion protein including a cell-penetrating peptide and an LRR domain derived from the NLRX1 protein. Since the fusion protein can effectively inhibit and alleviate the disease severity of autoimmune diseases and directly regulates T cell functions, it can be usefully used to treat or prevent autoimmune diseases.
Claims10
A fusion protein comprising, at one end of (a) a cell-penetrating peptide represented by SEQ ID NO 1, (b) a peptide comprising a LRR domain derived from the NLRX1 protein represented by SEQ ID NO 2.
Dependencies are inferred from the claim text.